Dyadic to present at industry and investor events in october
Jupiter, fla., sept. 29, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be presenting at the following industry and investor events during the month of october: enzyme engineering xxvii, october 1-6, 2023park royal hotel, singaporedr. ronen tchelet, chief scientific officer “the use of in silico analysis to engineer the best immunogenic epitope and produce the corresponding prophylactic antigen-based vaccines with c1 production platform in order to rapidly respond to viral pandemics” wednesday, october 4, 2023, 11:00 am – 11:30 am ld mirco main event xvi, october 3-5, 2023luxe sunset blvd hotel, los angeles, camark emalfarb, president, and chief executive officer “next generation proteins for world health, nutrition and wellness” wednesday, october 4, 2023, 8:00 am – 8:25 am world vaccine congress europe, october 16-19, 2023fira de barcelona montjuic, barcelona, spainmark emalfarb, president, and chief executive officer “rapid development and flexible scale manufacturing of complex recombinant proteins and antigens including ferritin nanoparticles for seasonal and pandemic influenza vaccines” wednesday, october 18, 2023, 11:45 am – 12:00 pm if you would like to connect with dyadic's management at any of the events, you may request a one-on-one meeting at jlavalley@dyadic.com.
